Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 9Gynecologic 5Gastrointestinal 4Thoracic 3Head & Neck 3Tumor-Agnostic 2Genitourinary 2Plasma cell 1Other hematologic neoplasm 1Other 1Myeloid 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Neoplasms 1Multiple Myeloma 1Emotional Regulation 1

Interventions

Dexamethasone 882Bortezomib 481Lenalidomide 467Cyclophosphamide 367Melphalan 276Calcium Dobesilate 265daratumumab 241pomalidomide 216carfilzomib 188fludarabine phosphate 141fludarabine 137Thalidomide 125Peripheral Blood Stem Cell Transplantation 120Filgrastim 115ixazomib 94Mycophenolic Acid 91Granulocyte Colony-Stimulating Factor 90Busulfan 89Whole-Body Irradiation 88dexamethasone acetate 87Tacrolimus 79dexamethasone 21-phosphate 74isatuximab 70Cyclosporine 68auricularum 67Prednisone 67elotuzumab 63belantamab mafodotin 60Antilymphocyte Serum 56Etoposide 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Population Groups × Plasma cell × Clear all
NCT07236021 2025-11-21

e-Motion : Promoting Emotion Regulation in Chronic Cancer

Université Libre de Bruxelles

Phase NA Recruiting
30 enrolled
Plasma cell

Emotional Regulation, Multiple Myeloma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡